Will Glenmark’s COVID-19 drug give it a new lease of life or just a short energy boost?
The pharma major has taken a different path from peers, in launching a new drug instead of inking a licensing deal
Shruti Venkatesh - July 04, 2020
Catching 'em young
The licensing and merchandising market is coming of age as franchisees look at novel ways to monetise toons
Himanshu Kakkar - December 19, 2014